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Introduction. Tominimize delay between presentation, diagnosis, and treatment of cutaneousmelanoma (CM), a national fast-track
referral system (FTRS) was implemented in Denmark.The aim of this study was to analyze the referral patterns to our department
of skin lesions suspicious of melanoma in the FTRS. Methods. Patients referred to the Department of Plastic Surgery and Breast
Surgery in Zealand University Hospital were registered prospectively over a 1-year period in 2014. A cross-sectional study was
performed analyzing referral patterns, including patient and tumor characteristics. Results. A total of 556 patients were registered
as referred to the center in the FTRS for skin lesions suspicious of melanoma. Among these, a total of 312 patients (56.1%) were
diagnosed with CM. Additionally, 41 (7.4%) of the referred patients were diagnosed with in situ melanoma.Conclusion. In total, 353
(63.5%) patients had a malignant or premalignant melanocytic skin lesion. When only considering patients who where referred
without a biopsy, the diagnostic accuracy for GPs and dermatologists was 29% and 45%, respectively. We suggest that efforts of
adequate training for the referring physicians in diagnosing melanocytic skin lesions will increase diagnostic accuracy, leading to
larger capacity in secondary care for the required treatment of malignant skin lesions.
1. Introduction
Cutaneousmelanoma (CM) is an aggressive tumor of the skin
melanocytes. It is a growing health concern with a globally
increasing incidence in fair-skinned populations over the last
few decades [1]. The cause of CM is probably multifactorial
but for the most part attributed to an increase of exposure to
UV radiation [1, 2].
To minimize delay between presentation, diagnosis, and
treatment ofCM, theDanishHealth andMedicinesAuthority
implemented a national fast-track referral system (FTRS),
which also includes that the surgical management of primary
melanoma is according to national clinical guidelines. Other
skin malignancies, such as basal cell carcinoma (BCC) and
squamous cell carcinoma (SCC), are not intended to be
referred through this system. The aim of the national FTRS
was “that cancer patients should experience a well-organized,
comprehensive process without undue delay in connection with
the clinical evaluation, initial treatment and rehabilitation and
palliative care, with the aim to improve the prognosis and
quality of life for patients” [3].
The Department of Plastic Surgery & Breast Surgery,
Zealand University Hospital, provides a regional health ser-
vice to a population base of approximately 820.000 inhabi-
tants in Zealand Region inDenmark, representing nearly 15%
of the country’s total population.The incidence of melanoma
in Zealand Region in a five-year period in 2010 to 2014
increased from 245 to 445 patients, including MIS [4]. In the
recent years, this incidence has amounted to approximately
14-15% of the diagnosed CM in the total population, and this
regional incidence is slightly increasing correspondingly with
the national incidence in Denmark [5].
In theDanish health care system, the general practitioners
(GPs) function as gatekeepers for consultant dermatologists,
plastic surgeons, and plastic surgery departments, where
treatment of CM is performed. The Danish national FTRS
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Table 1: Results of referrals in the fast-track referral system for skin lesions suspicious of melanoma.
Females Males Total 𝑃 value
𝑁 (%) 293 (52.7) 263 (47.3) 556 <0.05
Age (mean ± SE) 57 ± 1.0 60 ± 1.0 58 ± 0.7 <0.05
CM 170 142 312 <0.05
In situ (%) 23 (56.1) 18 (43.9) 41 ns
NMSC 13 16 29 ns
Benign 86 85 171 ns
CM: cutaneous melanoma.
NMSC: non-melanoma skin cancer.
for skin lesions suspicious of melanoma implies that a patient
who presents with a lesion suspicious of CM is offered
an excision biopsy in secondary care within six days. This
allows confirmation of the diagnosis within two weeks and
permits the second stage of definitive wider excision and
sentinel lymph node biopsy (SLNB) to be based on tumor
characteristics such as the Breslow thickness, mitotic activity,
or presence of ulceration, which is then offered within nine
days. If SLNB is positive for metastasis, the patient is offered
the third stage comprising radical lymph node dissection
within two weeks.
Our plastic surgery department receives referrals regard-
ing lesions suspicious of melanoma from GPs, dermatolo-
gists, private plastic surgery clinics, or other specialties for
clinical evaluation and treatment. If a biopsy is made prior to
the referral, the patients are offered further treatment in the
department depending on the histological examination of the
biopsy.
The aim of this study was to analyze the referral patterns
of suspicious melanocytic skin lesions to our department in
the FTRS. We hypothesize that a relatively large proportion
of the referrals will present with skin lesions other than
CM, leaving room for improving diagnostic accuracy in
the primary health care sector. Therefore, the objective
was to characterize the referrals in the FTRS of suspected
or classified CM, in order to clarify from which health
services the referrals originate and how many of the referred
patients had in situ melanoma (MIS), invasive cutaneous
melanoma (CM), non-melanoma skin cancer (NMSC), or
benign lesions.
2. Methods
2.1. Study Design and Setting. Patients referred in the FTRS
to the Department of Plastic Surgery and Breast Surgery
in Zealand University Hospital, because of a lesion suspi-
cious of CM or with a biopsy-verified CM, were registered
prospectively in a population-based cross-sectional study
of the Zealand Region consisting of approximately 820.000
inhabitants in Denmark.
2.2. Participants. This study included patients over a 1-year
period in 2014, who had undergone surgical biopsy in general
practice, by dermatologists, in private plastic surgery clinics
or in other medical specialties and who were referred to our
department for further treatment. Patients who were referred
by the above health services because of a suspicious lesion
without a biopsy prior to the referral were also included. In
the first visit to the outpatient clinic, the patientwas examined
clinically and by manual dermatoscopy, and a total body skin
examination was performed. Also, the patient was offered an
immediate excision biopsy under local anesthesia, if a biopsy
was not performed prior to the referral. The patients were
scheduled after two weeks for suture removal and results of
histology. Patients who did not show up to the consultation
or who did not want to have an excision biopsy performed
and patients with metastatic melanoma of unknown primary
origin were excluded from the study.
2.3. Variables. Variables are patient age, sex, anatomical
location of the lesion, tumor characteristics, and from which
health services the referrals originated were registered, along
with whether or not a biopsy had been performed prior to
referral. All cases were coded as in situ melanoma (MIS),
invasive cutaneous melanoma (CM), non-melanoma skin
cancer (NMSC), or benign lesions.
The histological examinations of all the tumor biopsies
were conducted at the Department of Pathology, Roskilde
University Hospital.
2.4. Statistical Methods. All data were tested for distribution
of normality and treated statistically accordingly. Compari-
son between groups was tested by two-tailed t-test and in the
case of skewness or few numbers among groups the Mann-
Whitney 𝑈 test for nonparametric data was performed. Sta-
tistical significancewas set at𝑃 < 0.05. All data were analyzed
using the statistical program PAST (ver. 3.09).
3. Results
3.1. Participants. A total of 565 patients were prospectively
registered as referred to the center in the FTRS for skin lesions
suspicious of melanoma (Table 1). Of the referred patients,
two patients never showed up, one patient did not eventually
want a biopsy taken, and seven patients had metastatic
melanoma of unknown primary origin demonstrated by
PET-CT scan. These nine patients were excluded from the
database.
3.2. Data. Most of the patients (393; 70.7%)were referred due
to a suspicion of CM and had an excision biopsy taken on
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Table 2: Origin of the referrals in the fast-track referral system and the proportion of diagnosed CM and diagnostic accuracy.
GP Derm. PS Other Total
Referrals 88 441 5 22 556
(i) Without biopsy 55 321 0 17 393
CM diagnosed with biopsy prior to referral 31 106 5 5 113
CM verified with biopsy after referral 16 145 0 4 199
CM in total 47 251 5 9 312
CM: cutaneous melanoma.
Derm.: dermatologist.
PS: plastic surgeon.
Table 3: Age, gender, and Breslow thickness (%).
Age Females Males
≤1mm >1–4mm >4mm ≤1mm >1–4mm >4mm
20–40 (11.8) 20 (1.8) 3 0 (4.2) 6 (2.8) 4 0
41–55 (26.5) 45 (7.6) 14 0 (11.3) 16 (5.6) 8 (0.7) 1
56–70 (19.4) 33 (5.3) 9 (1.8) 3 (24.6) 35 (12.7) 18 (1.4) 2
>70 (11.2) 19 (8.2) 14 (5.3) 9 (16.9) 24 (13.4) 19 (4.2) 6
Total (68.8) 117 (22.9) 40 (7.1) 12 (57.0) 81 (34.5) 49 (6.3) 9
Table 4: Distribution on Breslow thickness of referrals originating
from GPs or dermatologists when biopsy is performed prior to and
after referral.
Referrals Breslow thickness
≤1mm >1–4mm >4mm Unclassified
GP
+ biopsy∗ 21 7 2 1
÷ biopsy∗ 9 4 3 0
Dermatologist
+ biopsy 58 40 4 4
÷ biopsy 89 45 11 0
∗+ biopsy: biopsy performed prior to referral.
÷ biopsy: biopsy performed after referral.
the first visit, whereas 159 (28.6%) patients were referred due
to a biopsy-verified CM.
A total of 312 patients (56.1%) were eventually diagnosed
with CM, significantly more females than males (𝑃 <
0.05). The rest of the referred patients were diagnosed with
MIS (41; 7.4%), NMSC (29; 5.2%), or various benign skin
lesions (171; 30.8 %) with no significant difference between
males or females (Table 1). Most referrals (441; 79.3%) were
from dermatologists and only five from plastic surgeons
(Table 2). Of the 393 patients without a biopsy prior to the
referral, 55 patients were referred by GPs, 321 patients by
dermatologists, and 17 patients by other specialties. Of the
patients referred by GPs and dermatologists, a total of 16 and
145 patients, respectively, were diagnosed with CM (Table 2),
leading to a diagnostic accuracy of 29% for GPs and 45% for
dermatologists.
When Breslow thickness was analyzed according to age
groups and sex (Table 3), the largest proportion of both sexes
was in the group of thin melanomas (≤1mm). However, this
number was only statistically significant for females (𝑃 =
0.044 versus males 𝑃 = 0.47). There was a tendency for a
relatively larger distribution of males in the middle group
of CM thickness, compared to females, but this finding
was not statistically significant (Table 3). There were no
major differences in distribution on Breslow thickness of the
referrals originating fromGPs or dermatologists when biopsy
is performed prior to and after referral (Table 4). However,
there might be a tendency towards a larger proportion of thin
melanomas excised by GPs.
All of the included patients were seen after referral within
the recommended time period and there was no difference in
timing according to who was referring the patient. Further-
more, all patients diagnosed with CM had a definitive wider
excision performed based on tumor characteristics in accor-
dance with national guidelines for treatment of melanoma,
including SLNB and radical lymph node dissection, if these
were indicated.
4. Discussion
This is the first population-based cross-sectional study in
Denmark that provides insight into the diagnostic accuracy of
referrals of patients with skin lesions suspicious ofmelanoma,
and the referring physicians’ ability to differentiate between
CM, NMSC, and benign lesions. Of all the referred patients,
a total of 312 patients (56.1%) were diagnosed with CM and
41 patients were diagnosed with MIS (7.4%), whereas 200
patients had NMSC or benign lesions (35.9%).The FTRS can
improve rapid access for patients with CM, but only when
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used appropriately due to increased education, clear commu-
nication, and improved technology for consistent detection
of cancers [6]. A study has demonstrated that physicians can
benefit from using dermatoscopy to differentiate between
pigmented lesions, and this could possibly reduce the unnec-
essary referrals [7]. However, this requires proper training
and regular use of dermatoscopy in order to improve from
its supplementary assessment and therefore it is questionable
whether GPs have the time required to gain sufficient experi-
ence in using dermatoscopy.
In our presented data, most referrals (441; 79.3%) were
from dermatologists and only five from plastic surgeons
(Table 2). This fact reflects that in the Zealand Region there
are several practitioners in dermatology and none in plastic
surgery. Also, this might indicate that most of the patients
were referred to a dermatologist by theGPs initially, and these
were further referred to our department in the FTRS because
of continued clinical suspicion of CM (321; 57.7%) or because
a biopsy performed by the dermatologist had verified the
diagnosis of CM (106; 19.1%).When evaluating the diagnostic
accuracy, the referringGPs had a lower accuracy compared to
dermatologists (29% versus 45%), which is not unexpected
since most GPs in general do not use dermatoscopy and have
a lower experience in diagnosing pigmented skin lesions.
Cutaneous melanoma is still a skin cancer with the high-
estmortality despite all the preventive and therapeutic efforts,
and this is also despite CM being less common than other
non-melanoma skin cancers [8]. Breslow thickness, mitotic
activity, and ulceration are associated with an increased
risk of metastatic potential and mortality. Therefore, early
diagnosis of CM at an initial and curable stage is essential
for increasing the survival rate of patients [8]. However,
waiting list times for dermatologists have increased and
several referred lesions, which are a combination of benign
and malignant lesions, can result in a puzzling and inefficient
situation where early diagnosis can become challenging for
patients who actually do have a malignant lesion. Similar
fast-track referral systems, as the one described in our study,
have also been implemented in the United Kingdom (UK)
in 2000 [9]. When an evaluation of the 2-week rule in the
UK was made in 2004, it revealed that the referral system
was not working as expected in terms of early recognition
and skin cancer diagnosis, because only 12% of the referrals
had a potentially metastatic tumor such as squamous cell
carcinoma (SCC) or melanoma [10]. As presented in our
study, the patients with CM amounted to 312 (56.1%) of all
the referred patients. Additionally, a total of 41 (7.4%) of the
referred patients in our study were diagnosed with MIS. This
means that a total of 353 (63.5%) patients had a malignant or
premalignant melanocytic lesion, which demonstrates that it
is still desirable to improve the diagnostic accuracy of CM in
the primary sector, and this is further highlighted when only
considering the patients who were referred without a biopsy,
where the diagnostic accuracies for GPs and dermatologists
were 29% and 45%, respectively.
By using this referral system, it is understandable and
appropriate that some referrals will be made on the basis of
doubt, especially if the referring physician is less experienced.
Also, some physicians may experience pressure from patients
and their concerns of increased waiting times for having
routine referrals [11]. In Australia, where there is a high
prevalence of skinmalignancy, it has been a target to improve
awareness and diagnostic skills in Australian GPs for skin
malignancies, which has led to improved accuracy and
appropriate referral to specialists [12]. In Italy, a formal 4-
hour training session on diagnostic and referral accuracy
of family doctors in melanoma screening was given to GPs,
resulting in improved specificity of suspicious pigmented skin
lesion referrals for melanoma from 55% to 73.1% (𝑃 < 0.001)
without significant loss in sensitivity [13]. However, another
evaluation in the UK of the 2-week rule after a targeted
continuing medical education showed surprisingly that the
rate of correctly referred patients with suspected skin malig-
nancies remained low regardless of the education module
[14].
Recent evidence has shown that the increase in the
incidence of CM is due to a generally higher awareness of skin
cancer and the improved strategies for early recognition and
diagnosis of suspicious melanocytic lesions. This is resulting
in an increasing incidence of early stage melanomas [1].
However, a population-based study presented an increasing
incidence of thick CM as well as an increase in incidence of
all the other categories of Breslow thickness [15]. Hence, it
is essential to ensure that the referrals of patients in FTRS
are optimized, to limit unnecessary referrals, in order to gain
capacity for the relevant category of patients with CM in the
secondary care. Furthermore, distribution of CM over body
surface is not only on sun-exposed areas, which indicates the
importance of total body skin examination [16]. However,
this is rarely performed by the referring physicians, including
dermatologists, and thus, it is performed for the first time
during patients’ visit to the outpatient clinic. Unawareness
of the lesion distribution or the time pressure in the clinics
may explainwhy the referring physicians donot perform total
body skin examination [16, 17], and this might possibly lead
to delayed diagnosis of CM.
A limitation to our study is that this is a single center
study based on the figures of one region of the country.
However, Denmark is a relatively homogenous country with
an even distribution of CM [5], and therefore, the 820.000
inhabitants in Zealand Region are likely representative of the
effect and quality of the FTRS. Also, we are aware that we
do not have any comparative data from the period before
implementation of FTRS. However, since this was a cross-
sectional study our objective was to perform a descriptive
analysis of the current referral patterns of suspicious skin
lesions to our department. Therefore, we conclude that since
a definitive screening program for CM does not exist in
many countries, it is essential to detect atypical melanocytic
skin lesions early and correctly refer these to secondary
care, where effective and timely management of CM can be
performed. An increase in the level of diagnostic accuracy
from the referring physicians is required in order to optimize
the precision of the referrals to FTRS.Thismight be achieved,
for example, by formal training sessions or performance of an
excision biopsy, leading to an increased diagnostic accuracy
and thereby improving and reserving the FTRS to the relevant
patients.
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